Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Østergaard

Showing results (291-300 of 403) with videos related to

Pageof 41
Sort By:
Arthritis and Rheumatism|April 29, 2006
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled studyMerete Lund Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Arthritis Research & Therapy|July 14, 2021
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trialMarit Stockfelt, Anna-Carin Lundell, Merete Lund Hetland, et al.
RMD Open|December 31, 2024
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot studyBas Dijkshoorn, Romy Hansildaar, Daisy Vedder, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2023
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialKristina Lend, Frieda A Koopman, Jon Lampa, et al.
The Journal of Rheumatology|May 17, 2011
Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritisAnne F Christensen, Hanne Lindegaard, Kim Hørslev-Petersen, et al.
Journal of Internal Medicine|April 7, 2026
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritisKristina Lend, Jos W R Twisk, Frieda A Koopman, et al.
The Journal of Rheumatology|December 3, 2013
Update on the OMERACT magnetic resonance imaging task force: research and future directionsPhilip G Conaghan, Fiona M McQueen, Paul Bird, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb StudyXenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritisYibo He, Outi Sareila, Linda Johansson, et al.
Arthritis Research & Therapy|July 27, 2025
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohortTahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, et al.
Pageof 41

Showing results (291-300 of 403) with videos related to

Sort By:
Pageof 41
Arthritis and Rheumatism|April 29, 2006
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled studyMerete Lund Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Arthritis Research & Therapy|July 14, 2021
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trialMarit Stockfelt, Anna-Carin Lundell, Merete Lund Hetland, et al.
RMD Open|December 31, 2024
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot studyBas Dijkshoorn, Romy Hansildaar, Daisy Vedder, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2023
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialKristina Lend, Frieda A Koopman, Jon Lampa, et al.
The Journal of Rheumatology|May 17, 2011
Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritisAnne F Christensen, Hanne Lindegaard, Kim Hørslev-Petersen, et al.
Journal of Internal Medicine|April 7, 2026
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritisKristina Lend, Jos W R Twisk, Frieda A Koopman, et al.
The Journal of Rheumatology|December 3, 2013
Update on the OMERACT magnetic resonance imaging task force: research and future directionsPhilip G Conaghan, Fiona M McQueen, Paul Bird, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb StudyXenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritisYibo He, Outi Sareila, Linda Johansson, et al.
Arthritis Research & Therapy|July 27, 2025
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohortTahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, et al.
Pageof 41